Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Clinical trial NCT01347788 · COMPLETED

Trial details

NCT number: NCT01347788
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Adenocarcinoma

Start date: 2011-04-01
Primary completion: 2013-05-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.